#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicle centre lymphoma follicular grade I II – III refractory Cushing's syndrome Paget's disease of the vulva HER2 gene amplification Arterial disorder Cholestatic pruritus Endometrial adenocarcinoma Lupus nephritis Cutaneous T-cell lymphoma refractory Dilated cardiomyopathy Systemic mastocytosis Chronic graft versus host disease in liver Non-small cell lung cancer recurrent Prader-Willi syndrome Acromegaly More trials…

    Learn about Rare Diseases

    Paroxysmal nocturnal haemoglobinuria Inclusion body myositis – Treatment Progressive supranuclear palsy – Diagnostics IgA nephropathy – Treatment Mucopolysaccharidosis II – Diagnostics Glomerulonephritis rapidly progressive – Diagnostics Biotinidase deficiency – Treatment Thrombotic thrombocytopenic purpura – Diagnostics Soft tissue sarcoma – Treatment Biotinidase deficiency – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Odevixibat Sodium Iodide (123 I) Interferon Beta-1A Troriluzole Oxytocin Fluindione Belatacept Tamuzimod Acetate Iclepertin Gemlapodect Pyridoxine Gsk6097608 Adapalene Adg126 Vilanterol XYLOMETAZOLINE HYDROCHLORIDE Goserelin Acetate Evx-01 Magnesium Hydroxide Gadoxetic Acid, Disodium More therapies…

    Learn about Your Condition

    Metastasis Adenocarcinoma Muscle injury Optic atrophy Venous thrombosis limb Short-bowel syndrome Cervix carcinoma stage IV Arrhythmia Clostridium difficile colitis Urethral stenosis Cardiac failure congestive Neurotrophic keratopathy PIK3CA-activated mutation Autism spectrum disorder Hairy cell leukaemia recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Genetic Phenomena

  • Study on DB-OTO for Safety and Tolerability in Infants and Children with Genetic Hearing Loss

    Recruiting

    2 1 1
    Investigated Diseases:
    • Deafness
    Investigated Drugs:
    • Db-Oto-3
    • Db-Oto-5
    Germany Spain

  • Study on the Effects and Safety of Alpelisib for Children and Adults with Megalencephaly-Capillary Malformation Polymicrogyria Syndrome

    Recruiting

    2 1 1
    Investigated Diseases:
    • PIK3CA related overgrowth spectrum
    Investigated Drugs:
    • Alpelisib
    France

  • Study on the Effects of Inaxaplin for Adults and Children with APOL1-mediated Proteinuric Kidney Disease

    Recruiting

    4 1
    Investigated Drugs:
    • Inaxaplin
    Belgium France

  • Study of Vosoritide Safety and Effectiveness in Infants and Young Children (0 to 36 months) with Hypochondroplasia

    Recruiting

    2 1 1
    Investigated Drugs:
    • Vosoritide
    France Germany Italy

  • Study of MZE829 capsules for adults with APOL1 kidney disease and protein in urine

    Recruiting

    2 1 1
    Investigated Drugs:
    • MZE829
    France

  • Efficacy and Safety of Berotralstat for Preventing Angioedema Attacks in Patients with Acquired Angioedema due to C1 Inhibitor Deficiency

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Berotralstat
    Italy
Previous Page
1 2 3 4 … 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!